CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $52.43 $47.51 (+1.39%) -9.38% +1.00% -10.39
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $1.38 (+0.73%) -18.82% +1.00% -19.83
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.33 $36.90 (+3.10%) -16.76% +1.00% -17.76
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $1.70 (+1.80%) -12.37% +1.00% -13.37
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $34.37 $28.48 (+3.68%) -17.14% +1.00% -18.14
17/03/2014 ANV.US 2 out of 5 Outperform 5Y $6.37 $3.84 (+7.56%) -39.72% +1.00% -40.72
17/03/2014 GG.US 3 out of 5 Outperform 5Y $28.45 $24.71 (+0.98%) -13.14% +1.00% -14.15
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $324.58 (-1.44%) +80.62% +36.49% -44.14
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $4.49 (+4.42%) -27.70% +25.20% -52.90
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.96 (+1.28%) -11.41% +23.53% -34.94
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $16.77 $13.07 (+2.75%) -22.08% +23.53% -45.61
05/02/2013 RIC.US 3 out of 5 Outperform 5Y $3.20 $1.27 (+3.00%) -60.31% +24.68% -84.99
05/02/2013 AXU.US 2 out of 5 Outperform 5Y $4.58 $1.36 (+3.82%) -70.31% +24.68% -94.98
04/02/2013 SSRI.US 3 out of 5 Outperform 5Y $12.09 $9.92 (+2.27%) -17.95% +24.70% -42.65
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $12.77 $4.75 (-0.21%) -62.80% +24.70% -87.50
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.70 (+10.76%) -72.12% +25.68% -97.80
23/01/2013 NRT.US 3 out of 5 Outperform 1Y $22.71 $24.19 (+1.09%) +6.53% +25.70% -19.16
23/01/2013 POT.US 4 out of 5 Outperform 5Y $39.68 $35.14 (-1.29%) -11.44% +25.70% -37.14
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $9.56 (+4.71%) +83.14% +25.70% +57.45
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $3.55 (+2.90%) -66.45% +27.61% -94.06
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.